Cargando…
Immune cell engagers in solid tumors: promises and challenges of the next generation immunotherapy
In the landscape of cancer immunotherapy, immune cell engagers (ICEs) are rapidly emerging as a feasible and easy-to-deliver alternative to adoptive cell therapy for the antitumor redirection of immune effector cells. Even if in hematological malignancies this class of new therapeutics already hit t...
Autores principales: | Fucà, G., Spagnoletti, A., Ambrosini, M., de Braud, F., Di Nicola, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841318/ https://www.ncbi.nlm.nih.gov/pubmed/33508733 http://dx.doi.org/10.1016/j.esmoop.2020.100046 |
Ejemplares similares
-
Revolution of CAR Engineering For Next-Generation Immunotherapy In Solid Tumors
por: Yu, Tao, et al.
Publicado: (2022) -
What’s next in cancer immunotherapy? - The promise and challenges of neoantigen vaccination
por: Redwood, Alec J., et al.
Publicado: (2022) -
Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy
por: Naseri, Marzieh, et al.
Publicado: (2020) -
VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapy
por: Shekari, Najibeh, et al.
Publicado: (2023) -
Next Generation Imaging Techniques to Define Immune Topographies in Solid Tumors
por: Pietrobon, Violena, et al.
Publicado: (2021)